Home LiteratureArticle Details
PMID: 11803566 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Insulin-like growth factor I stimulates myoblast expansion and myofiber development in the limb.

Mitchell PJ, Johnson SE, Hannon K

Abstract

Insulin-like growth factor I (IGF-I) is expressed in the anterior and posterior mesodermal cells of the developing limb. However, a definite role for IGF-I during early limb organogenesis is unknown. To determine the inherent participation of IGF-I during limb organ development, a retroviral delivery system (RCAS) was used to overexpress IGF-I throughout the developing hind limb of stage 24 chicken embryos. The area of the belly of the external gastrocnemius muscle in the IGF-I infected limb was an average of 160, 90, 70, and 80% larger than the contralateral control muscle belly, 4, 5, 6, and 7 days postinjection, respectively (all differences P < 0.01). In comparison to the contralateral control muscles, there were a significantly greater number of muscle fibers in the IGF-I infected muscles (P < 0.05), confirming that the majority of IGF-I-mediated muscle enlargement was due to an increase in total fiber numbers (hyperplasia). Four days postinjection, there was a 32% increase in myoblast to myofiber ratio in the muscle of injected limbs compared with the muscle in the contralateral noninjected control limbs (P < 0.05). This result demonstrates that IGF-I acts to expand the undifferentiated myoblast population, and as a result, more myofibers subsequently develop, and the muscles expressing ectopic IGF-I are enlarged by means of hyperplasia. There was no difference in tibiotarsus and fibula length or diameter between the IGF-I injected and control limb, suggesting that ectopic IGF-I expression within the mesoderm was not a nonspecific growth stimulant of all tissues of the developing limb, but specifically enhanced skeletal muscle development and growth. Ectopic IGF-I expression had no significant effect on myostatin mRNA concentrations. Our results support a model where mesodermally expressed IGF-I acts to regulate the number of primary myofibers, and, therefore, size of skeletal muscles, which form during the initial events of limb myogenesis.

MeSH Terms
Animals Chick Embryo Extremities/embryology Immunohistochemistry/methods Insulin-Like Growth Factor I/genetics,metabolism Microinjections Morphogenesis Muscle, Skeletal/cytology,growth & development,metabolism Myostatin Retroviridae/genetics,metabolism Transforming Growth Factor beta/genetics,metabolism
Chemicals
Myostatin Transforming Growth Factor beta Insulin-Like Growth Factor I
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Mitchell Pamela J
Department of Basic Medical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, USA.
Johnson Sally E
Hannon Kevin
Article Info
Journal
Developmental dynamics : an official publication of the American Association of Anatomists
Abbr.
Dev Dyn
ISSN
1058-8388
Published
2002-01-00
Pages
12-23
Language
English
Region
United States
NLM ID
9201927
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com